Sarah Melton, APD
Sarah Melton is an Accredited Practising Dietitian with extensive experience across hospital and private practice settings in metropolitan Melbourne. She is known for her compassionate, evidence-based approach to supporting individuals with complex gastrointestinal conditions.
Sarah completed her Bachelor of Nutrition and Dietetics at Monash University and currently works as a senior clinical dietitian at a major tertiary public hospital. In this role, she provides expert nutritional care to patients with a broad range of gastrointestinal conditions, including inflammatory bowel disease (IBD), disorders of gut-brain interactions (including Irritable Bowel Syndrome) and those undergoing gastrointestinal surgery.
Sarah is also undertaking a PhD at Monash University, where she is investigating the effects of Exclusive Enteral Nutrition in patients with Crohn’s disease. Her research is supported by a publicly funded research grant and a Crohn’s & Colitis Australia PhD scholarship, reflecting her commitment to advancing clinical care through research. Sarah has published her work in peer-reviewed journals and presented at international and national Gastroenterology conferences. Sarah is a Co-Founder, board member and Head of Communications and Engagement at GI Dream (Gastrointestinal Dietitians in Research Education Advocacy and Mentoring), a health promotion charity focusing on improving the role of diet in gastrointestinal disease.
Sarah has a special interest in the role of diet in managing inflammatory bowel disease and is passionate about delivering high-quality, personalised nutrition support for people living with IBD, eosinophilic oesophagitis, coeliac disease, and functional gut disorders such as IBS. Her approach blends scientific knowledge with practical, real-world strategies to help her clients improve their gut health and quality of life.
Sarah sees patients in-person at Brighton Gastroenterology Associates. Please contact their clinic directly for a face-to-face appointment, on 03 9591 0466 or reception@brightongastro.com
Research
Melton S, Abdelmalak J, Burgell R, Fitzpatrick JA. The Importance of Dietary Measures for
Clinical Utility. Am J Gastroenterol. 2025;00-1. DOI: 10.14309/ajg.0000000000003260
Melton S, Swaminathan A, Fitzpatrick J. Letter: Exclusive Enteral Nutrition in Ulcerative Colitis— The Path Ahead Needs Careful Consideration. Aliment Pharmacol Ther. 2025;61: 1577-
1578. https://doi.org/10.1111/apt.70091
Melton SL, Day AS, Bryant RV, Halmos EP. Revolution in diet therapy for inflammatory bowel disease. JGH Open. 2024;8:e13097. DOI: doi:10.1002/jgh3.13097.
Melton SL, Halmos EP. Editorial: One step closer to personalised nutrition therapy for irritable bowel syndrome. Aliment Pharmacol Ther. 2023;58:554-554. https://doi.org/10.1111/apt.17633
Commins I, Clayton-Chubb D, Melton S, Majeed A, Kemp W, Roberts SK. Initial outcomes of a
dedicated multidisciplinary non-alcoholic fatty liver disease clinic: a retrospective cohort study. Intern Med J. 2023 Mar 7. doi: 10.1111/imj.16055. Epub ahead of print
Melton SL, Taylor KM, Gibson PR, Halmos EP. Review article: Mechanisms in underlying the effectiveness of exclusive enteral nutrition in Crohn’s disease. Aliment Pharmacol Ther. 2023;00:1-16. Doi:10.1111/apt.17451
Fitzpatrick J, Melton SL, Burgell RE. Dietary management of eosinophilic oesophagitis. Med J
Aust 2023; 219 (8): 340-343. || doi: 10.5694/mja2.52101
Melton SL, Fitzpatrick JA, Taylor KM, et al. Lessons from an audit of exclusive enteral nutrition in adult inpatients and outpatients with active Crohn’s disease: a single-centre experience. Frontline Gastroenterology. 2022 June 24. doi: 10.1136/flgastro-2022-102173
Fitzpatrick JA*, Melton SL*, Yao CK, Gibson PR, Halmos EP. Dietary management of adults with IBD – the emerging role of dietary therapy. Nat Rev Gastroenterol Hepatol 2022 Oct;19(10):652- 669. doi: 10.1038/s41575-022-00619-5. Epub 2022 May 16. *equal first-author contribution
Day A, Wood J, Melton S, Bryant R. Exclusive Enteral Nutrition: An optimal care pathway for use in adult patients with active Crohn's disease. JGH Open. 2019 Sep 10;4(2):260-266